Medicare Price Negotiation Will Continue Under Trump With Possible ‘Improvements’

 
• By Cathy Kelly

HHS Secretary nominee Robert F. Kennedy Jr. discussed the Trump Administration's support for Medicare price negotiation during his confirmation hearing.

Robert F. Kennedy Jr. testifies as US Senate Finance Committee
Robert F. Kennedy Jr. showed an interest in narrowing the difference between US prices and those in other countries. (Screenshot Of Senate Finance Committee Broadcast)

The Trump Administration will continue the second cycle of Medicare price negotiations, which includes 15 drugs selected by the Biden Administration, but also signaled that changes will be considered.

More from Drug Pricing

More from Business